Literature DB >> 31160439

QnAs with Hidde L. Ploegh.

Prashant Nair.   

Abstract

Year:  2019        PMID: 31160439      PMCID: PMC6589764          DOI: 10.1073/pnas.1908701116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  6 in total

1.  Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice.

Authors:  Yushu Joy Xie; Michael Dougan; Noor Jailkhani; Jessica Ingram; Tao Fang; Laura Kummer; Noor Momin; Novalia Pishesha; Steffen Rickelt; Richard O Hynes; Hidde Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-01       Impact factor: 11.205

2.  Noninvasive imaging of tumor progression, metastasis, and fibrosis using a nanobody targeting the extracellular matrix.

Authors:  Noor Jailkhani; Jessica R Ingram; Mohammad Rashidian; Steffen Rickelt; Chenxi Tian; Howard Mak; Zhigang Jiang; Hidde L Ploegh; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-08       Impact factor: 11.205

3.  Small but mighty.

Authors:  Mitch Leslie
Journal:  Science       Date:  2018-05-11       Impact factor: 47.728

4.  Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma.

Authors:  Marleen Keyaerts; Catarina Xavier; Johannes Heemskerk; Nick Devoogdt; Hendrik Everaert; Chloé Ackaert; Marian Vanhoeij; Francois P Duhoux; Thierry Gevaert; Philippe Simon; Denis Schallier; Christel Fontaine; Ilse Vaneycken; Christian Vanhove; Jacques De Greve; Jan Lamote; Vicky Caveliers; Tony Lahoutte
Journal:  J Nucl Med       Date:  2015-10-08       Impact factor: 10.057

5.  Naturally occurring antibodies devoid of light chains.

Authors:  C Hamers-Casterman; T Atarhouch; S Muyldermans; G Robinson; C Hamers; E B Songa; N Bendahman; R Hamers
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

6.  Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs.

Authors:  Alyson Haslam; Vinay Prasad
Journal:  JAMA Netw Open       Date:  2019-05-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.